Study 1 controls (n=7) | Study 2 controls (n=23) | P value | Study 1 T2D (n=10) | Study 2 T2D (n=23) | P value | |
Age (years) | 47±6 | 60±10 | 0.003 | 46±6 | 64±8 | <0.0001 |
Sex (M/F) | 4 M/3 F | 11 M/12 F | 7 M/3 F | 12 M/11 F | ||
BMI (kg/m2) | 29±4 | 28±3 | 0.640 | 36±7 | 32±4 | 0.03 |
Systolic BP (mm Hg) | 126±15 | 122±8 | 0.280 | 127±20 | 132±8 | 0.31 |
Diastolic BP (mm Hg) | 75±13 | 75±6 | 1.000 | 75±11 | 81±7 | 0.08 |
Duration of diabetes (years) | N/A | N/A | 3.3±2.3 | 4.5±2.2 | 0.14 | |
HbA1c (mmol/mol) | 33.6±2.9 | 37.2±2.2 | 0.004 | 49±12 | 51±11 | 0.62 |
HbA1c (%) | 5.2±0.3 | 5.6±0.2 | 0.006 | 6.6±1.0 | 6.8±1.0 | 0.48 |
Total cholesterol (mmol/L) | 5.1±0.8 | 4.8±0.77 | 0.230 | 5.3±0.7 | 4.2±1.0 | 0.36 |
Triglyceride (mmol/L) | 1.2±0.5 | 1.3±0.6 | 0.540 | 1.7±0.8 | 1.7±0.7 | 0.96 |
CRP (mg/L) | 0.8±0.0 | 5.1±10.3 | 0.26 | 2.8±1.8 | 3.1±2.9 | 0.94 |
Data are presented as mean±1 SD.
BMI, body mass index; BP, blood pressure; CRP, C reactive protein; F, female; HbA1c, hemoglobin A1c; M, male; T2D, type 2 diabetes.